REVB Q3 2021 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$20,416

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-8129.35

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$131,320

Balance Sheet

Total Assets

$6M

Total Liabilities

$2M

Stockholders' Equity

$4M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$20,416	$0	—
Operating Income	-$3M	-$868	-350585.1%
Net Income	-$3M	-$868	-350649.3%